查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045893

醫療領域AR/VR市場－全球產業規模、佔有率、趨勢、競爭機會及預測：按組件、設備類型、應用、最終用途、地區和競爭對手分類，2021-2031年

AR-VR in Healthcare Market - Global Industry Size, Share, Trends, Competition Opportunity, and Forecast, Segmented By Component, By Device Type, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療領域的 AR/VR 市場預計將從 2025 年的 49.6 億美元成長到 2031 年的 173.5 億美元，複合年成長率為 23.21%。

這些身臨其境型技術，包括擴增實境（AR）疊加和虛擬實境（VR）模擬，旨在利用數位資料日益成長的需求，這些工具能夠讓醫務人員在不危及患者安全的情況下進行練習。這些主要促進因素透過滿足全球醫療保健系統的基本安全性和效率需求，為該領域的長期擴張奠定了基礎。

市場概覽
預測期 2027-2031
市場規模：2025年 49.6億美元
市場規模：2031年 173.5億美元
複合年成長率：2026-2031年 23.21%
成長最快的細分市場 軟體
最大的市場 北美洲

儘管這些優勢顯而易見，但市場也面臨許多挑戰。特別是，硬體部署成本高昂以及可能阻礙即時臨床操作的技術延遲問題，都是主要擔憂。此外，為確保新型醫療軟體符合安全標準而進行的嚴格測試，也使得其廣泛應用更加困難。然而，監管方面正在取得進展。根據美國食品藥物管理局(FDA) 的報告，到 2025 年，將有 92 款擴增實境(AR) 和虛擬實境 (VR)醫療設備核准在放射學和整形外科等專科領域用於臨床。

市場促進因素

身臨其境型技術在醫學模擬和培訓中的日益普及，透過提供安全、高保真的技能發展環境，正在改變醫學教育。這些平台使醫護人員能夠在不危及病人安全的情況下反覆練習複雜的操作流程，從而有效地彌合了理論學習與臨床實踐之間的差距。越來越多的臨床研究證實了這些工具的有效性，加速了它們在醫院規範中的應用。例如，2025年2月《MedCity News》發表的一篇報導《培訓的未來：虛擬實境將如何保護臨床醫生》引用了一項研究，該研究表明虛擬實境培訓使醫護人員的手衛生依從性提高了68%。這項改進支持了身臨其境型模擬能夠比傳統方法更有效地糾正關鍵臨床習慣的觀點。

同時，擴增實境（AR）和虛擬實境（VR）技術在手術規劃和術中導航中的應用，透過提高侵入性手術的精準度，正在推動市場成長。最新的頭戴式裝置可將即時3D解剖資料直接疊加到外科醫生的視野中，無需將視線移至外部顯示器，從而提升了手術的人體工學安全性。這一轉變得益於早期應用。在2025年1月一篇報導中，《快公司》報道稱，加州大學聖地亞哥分校醫療中心已使用空間計算硬體管理術中數據，成功完成了50多例即時手術。這一發展勢頭也得到了大量資金籌措的支持。 《MedCity News》在2025年7月指出，數位醫療新創公司在當年上半年籌集了64億美元的創業投資，用於在全球推廣這些先進解決方案。

市場挑戰

硬體部署成本高昂是全球醫療保健領域AR/VR市場成長的主要障礙。高階身臨其境型設備，例如高解析度和觸覺回饋頭顯，價格昂貴，對許多醫療機構的資本預算造成了沉重負擔。對於小規模的醫院和門診中心而言，這項財務挑戰尤其嚴峻，因為它們通常優先考慮必要的診斷工具而非新興技術。此外，對高速處理單元和專用軟體授權等昂貴支援基礎設施的需求也增加了整體擁有成本（TCO），使得大規模部署對大多數市場參與者來說難以承受。

這些經濟限制因素直接阻礙了市場滲透，因為決策者往往會因為對投資報酬率的擔憂而推遲購買決策。據XR協會稱，2024年接受調查的醫療保健專業人員中，有30%的人對實施擴增實境（XR）計畫的成本表示擔憂。這項數據凸顯了普遍存在的預算摩擦，顯示儘管臨床益處已得到認可，但高昂的實施成本阻礙了相當一部分醫療保健機構採用這些工具，從而抑制了整體市場成長。

市場趨勢

基於虛擬實境（VR）的數位療法的興起正在重塑市場格局，它不再局限於娛樂，而是將身臨其境型環境確立為慢性病管理的臨床標準。這一趨勢著重於對作為醫療設備的軟體（SaMD）進行嚴格的臨床檢驗，以期為複雜的疼痛和心理健康問題提供非藥物療法。高品質的臨床數據為實證治療方案的轉變提供了支持，這些數據也證實了其長期療效。例如，AppliedVR於2024年12月發表的一篇報導「大規模臨床研究：家用VR設備為重度慢性疼痛患者提供更顯著的緩解」的文章報告了一項重要發現：70%的重度慢性疼痛患者在接受VR治療後，疼痛程度有所減輕。

同時，人工智慧與身臨其境型生態系統的融合正在提升擴增實境（XR）平台的診斷與預測能力。這一趨勢正從靜態3D視覺化發展到創建人工智慧驅動的動態數位雙胞胎，從而模擬患者的生理功能並即時預測手術結果。透過整合機器學習演算法，這些系統能夠分析大量資料集並制定個人化的治療方案，這項能力正引起監管機構的注意。正如MedTech Dive在2024年10月一篇題為《人工智慧醫療設備數量預計將在過去十年激增》的報導中所指出的，截至2024年8月，美國食品藥物管理局（FDA）已核准了950種人工智慧或機器學習設備，這為下一代身臨其境型已通過核准裝置整合了強大的演算法基礎。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球醫療領域AR/VR市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依組件（硬體、軟體）
    • 依設備類型（AR設備、VR設備）
    • 按應用領域（患者照護管理、醫療訓練、手術計畫、藥局管理等）
    • 依最終用途（醫院/診所、臨床研究中心、製藥公司、診斷檢查室）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美醫療保健產業的AR-VR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫療保健產業AR/VR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫療保健產業的AR/VR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲醫療領域AR/VR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲醫療保健領域AR/VR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球醫療保健領域AR/VR市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medical Realities Ltd.
  • Koninklijke Philips NV
  • Alphabet Inc.
  • Firsthand Technology Inc.
  • Augmedics Ltd.
  • 3D Systems Corporation
  • HTC Corporation
  • Samsung Electronics Co., Ltd.
  • Microsoft Corporation
  • HP Inc.
  • Carl Zeiss Meditec AG
  • MindMaze, Inc.
  • Siemens Healthineers AG
  • Osso VR, Inc.
  • EchoPixel, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7760

The Global AR-VR in Healthcare Market is projected to expand from USD 4.96 Billion in 2025 to USD 17.35 Billion by 2031, achieving a CAGR of 23.21%. These immersive technologies, comprising Augmented Reality overlays and Virtual Reality simulations, are designed to assist with medical training, surgical planning, and patient rehabilitation by either enhancing the physical world with digital data or creating fully simulated environments. The primary forces driving this market growth are the critical necessity for improved precision during complex surgeries and the increasing demand for risk-free educational tools that enable medical staff to practice without endangering patients. These key drivers underpin long-term expansion by addressing fundamental safety and efficiency needs within the global healthcare system.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.96 Billion
Market Size 2031USD 17.35 Billion
CAGR 2026-203123.21%
Fastest Growing SegmentSoftware
Largest MarketNorth America

Despite these benefits, the market faces significant hurdles, particularly the high cost of deploying hardware and technical latency issues that can interfere with real-time clinical procedures. Broad adoption is further complicated by the rigorous testing needed to ensure new medical software meets safety standards. However, regulatory progress is visible; the Food and Drug Administration reported that in 2025, there were 92 authorized augmented and virtual reality medical devices cleared for clinical use in specialties such as radiology and orthopedics.

Market Driver

The increasing use of immersive technologies for medical simulation and training is transforming healthcare education by offering safe, high-fidelity environments for skill development. These platforms permit medical professionals to rehearse complex procedures repeatedly without putting patients at risk, effectively bridging the divide between theoretical study and clinical practice. Clinical research increasingly validates the effectiveness of these tools, speeding up their adoption in hospital protocols; for example, a MedCity News article from February 2025 titled 'The Future of Training: How Virtual Reality Can Protect Clinicians' cited a study showing that virtual reality training improved healthcare workers' hand hygiene adherence by 68%. This improvement underscores the ability of immersive simulations to correct critical clinical habits more effectively than conventional methods.

Concurrently, the application of augmented and virtual reality in surgical planning and intraoperative navigation is fueling market growth by improving precision during invasive operations. Modern headsets can now overlay real-time 3D anatomical data directly into the surgeon's line of sight, eliminating the need to look away at external monitors and enhancing ergonomic safety. This shift is confirmed by early adoption; Fast Company reported in January 2025 in the 'How Apple Vision Pro is finding a home in healthcare' article that UCSD Health conducted over 50 live surgeries using spatial computing hardware to manage intraoperative data. This momentum is supported by substantial financial investment, with MedCity News noting in July 2025 that digital health startups raised $6.4 billion in venture capital in the first half of the year, funding the global expansion of these advanced solutions.

Market Challenge

The substantial cost of hardware deployment serves as a major barrier to the growth of the Global AR-VR in Healthcare Market. High-end immersive devices, such as headsets with high resolution and haptic feedback, come with premium price tags that burden the capital budgets of many medical facilities. This financial challenge is especially severe for smaller hospitals and outpatient centers, which often prioritize essential diagnostic tools over emerging technologies. Furthermore, the necessity for expensive supporting infrastructure, including high-speed processing units and specialized software licenses, increases the total cost of ownership, rendering full-scale implementation financially out of reach for a large portion of the market.

These economic limitations directly slow the rate of market penetration, as decision-makers frequently postpone purchasing decisions due to concerns over return on investment. According to the XR Association, in 2024, 30% of surveyed healthcare professionals expressed concern regarding the costs associated with implementing extended reality programs. This statistic highlights the widespread budgetary friction, indicating that despite the recognized clinical advantages, the high financial threshold prevents a significant segment of the medical community from adopting these tools, thereby stifling the overall growth of the market.

Market Trends

The rise of VR-Based Digital Therapeutics is reshaping the market by establishing immersive environments as a clinical standard for managing chronic conditions, moving beyond simple distraction methods. This trend focuses on the rigorous clinical validation of software as a medical device (SaMD) to provide non-pharmacological treatments for complex pain and mental health issues. The move toward evidence-based therapeutic protocols is backed by high-quality clinical data supporting long-term effectiveness. For instance, an AppliedVR article from December 2024 titled 'Large Clinical Study Finds Home-based Virtual Reality Device Creates Greater Relief for High Impact Chronic Pain Patients' reported a pivotal study in which 70% of high-impact chronic pain patients were reclassified to a lower-impact status following a virtual reality therapy program.

At the same time, the convergence of Artificial Intelligence with immersive ecosystems is improving the diagnostic and predictive powers of extended reality platforms. This trend advances beyond static 3D visualization to create dynamic, AI-driven digital twins that simulate patient physiology and forecast surgical outcomes in real time. Integrating machine learning algorithms enables these systems to analyze vast datasets for personalized treatment planning, a capability that is gaining regulatory traction. As noted by MedTech Dive in October 2024 in the 'The number of AI medical devices has spiked in the past decade' article, the Food and Drug Administration had authorized 950 AI or machine learning-enabled devices as of August 2024, establishing a strong foundation of cleared algorithms ready for integration into next-generation immersive headsets.

Key Market Players

  • Medical Realities Ltd.
  • Koninklijke Philips N.V.
  • Alphabet Inc.
  • Firsthand Technology Inc.
  • Augmedics Ltd.
  • 3D Systems Corporation
  • HTC Corporation
  • Samsung Electronics Co., Ltd.
  • Microsoft Corporation
  • HP Inc.
  • Carl Zeiss Meditec AG
  • MindMaze, Inc.
  • Siemens Healthineers AG
  • Osso VR, Inc.
  • EchoPixel, Inc.

Report Scope

In this report, the Global AR-VR in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AR-VR in Healthcare Market, By Component

  • Hardware
  • Software

AR-VR in Healthcare Market, By Device Type

  • AR Devices
  • VR Devices

AR-VR in Healthcare Market, By Application

  • Patient Care Management
  • Medical Training
  • Surgery Planning
  • Pharmacy Management
  • Others

AR-VR in Healthcare Market, By End Use

  • Hospitals & Clinics
  • Clinical Research Centers
  • Pharmaceuticals
  • Diagnostic Labs

AR-VR in Healthcare Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AR-VR in Healthcare Market.

Available Customizations:

Global AR-VR in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AR-VR in Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Hardware, Software)
    • 5.2.2. By Device Type (AR Devices, VR Devices)
    • 5.2.3. By Application (Patient Care Management, Medical Training, Surgery Planning, Pharmacy Management, Others)
    • 5.2.4. By End Use (Hospitals & Clinics, Clinical Research Centers, Pharmaceuticals, Diagnostic Labs)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America AR-VR in Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Device Type
    • 6.2.3. By Application
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States AR-VR in Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Device Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada AR-VR in Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Device Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico AR-VR in Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Device Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Use

7. Europe AR-VR in Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Device Type
    • 7.2.3. By Application
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany AR-VR in Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Device Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Use
    • 7.3.2. France AR-VR in Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Device Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom AR-VR in Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Device Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy AR-VR in Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Device Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain AR-VR in Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Device Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Use

8. Asia Pacific AR-VR in Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Device Type
    • 8.2.3. By Application
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China AR-VR in Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Device Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Use
    • 8.3.2. India AR-VR in Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Device Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan AR-VR in Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Device Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea AR-VR in Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Device Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia AR-VR in Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Device Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End Use

9. Middle East & Africa AR-VR in Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Device Type
    • 9.2.3. By Application
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia AR-VR in Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Device Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE AR-VR in Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Device Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa AR-VR in Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Device Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Use

10. South America AR-VR in Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Device Type
    • 10.2.3. By Application
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil AR-VR in Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Device Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia AR-VR in Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Device Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina AR-VR in Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Device Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global AR-VR in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medical Realities Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Koninklijke Philips N.V.
  • 15.3. Alphabet Inc.
  • 15.4. Firsthand Technology Inc.
  • 15.5. Augmedics Ltd.
  • 15.6. 3D Systems Corporation
  • 15.7. HTC Corporation
  • 15.8. Samsung Electronics Co., Ltd.
  • 15.9. Microsoft Corporation
  • 15.10. HP Inc.
  • 15.11. Carl Zeiss Meditec AG
  • 15.12. MindMaze, Inc.
  • 15.13. Siemens Healthineers AG
  • 15.14. Osso VR, Inc.
  • 15.15. EchoPixel, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer